Clinical Scorecard: Evaluating Factors Influencing Delays in Healthcare Access for Patients with Oral and Oropharyngeal Squamous Cell Carcinoma in Tanzania

At a Glance

Key Highlights

• OPSCC constitutes over a third of head and neck cancers worldwide.
• Five-year survival rates remain poor, particularly for advanced stages.
• Delays in diagnosis and treatment are significantly longer in low- and middle-income countries.
• Sociodemographic factors such as low education and socioeconomic status contribute to delays.
• Fear and denial regarding cancer diagnosis are common among patients.

Guideline-Based Recommendations

Diagnosis

• Timely referral from primary health care to specialized facilities.
• Improvement of histopathology services at regional hospitals.

Management

• Initiate treatment within the recommended 20 days post-diagnosis.

Monitoring & Follow-up

• Regular follow-up to assess treatment response and manage complications.

Risks

• Increased risk of late-stage presentation due to prolonged delays.

Patient & Prescribing Data

Adults aged 18 years and above with newly diagnosed OPSCC.

Access to chemotherapy and radiotherapy is centralized at the Ocean Road Cancer Institute.

Clinical Best Practices

• Enhance patient education on symptoms and the importance of early diagnosis.
• Streamline referral processes to reduce delays in treatment initiation.
• Address financial barriers to healthcare access for low-income patients.

References

• Global Cancer Observatory (GLOBOCAN) 2022 Data
• Study on diagnostic delays in India
• Tanzania cancer patient study